Hutch News

Hutch News

Stories tagged 'Peter Gilbert'

Computational biologist Dr. Raphael Gottardo receives 2018 Mortimer Spiegelman Award

American Public Health Association recognizes Fred Hutch researcher for his contributions to health statistics biology

July 13, 2018 | By Tom Kim / Fred Hutch News Service

The American Public Health Association has named Dr. Raphael Gottardo, a computational biologist at Fred Hutchinson Cancer Research Center, the winner of its 2018 Mortimer Spiegelman Award.

View story >

5 questions on dengue vaccine analysis

Asked to help re-examine clinical trial data, Fred Hutch biostatisticians foresee a new era of personalized vaccines

June 20, 2018 | By Mary Engel / Fred Hutch News Service

Asked to help re-examine clinical trials data, Fred Hutch biostatisticians foresee a new era of personalized vaccines

View story >

Malaria vaccine’s protectiveness depends on genetics of parasite

Genomics study, analysis help explain partial effectiveness, offer insights for improvement

Oct. 21, 2015 | By Mary Engel / Fred Hutch News Service

An experimental vaccine set to to win WHO approval as the first to even partially protect children against malaria works better against one strain of the disease-causing parasite than others.

View story >

Gut microbiome may have interfered with experimental HIV vaccines

Inoculating infants instead of adults could bypass problem, researchers say

July 30, 2015 | By Dr. Rachel Tompa / Fred Hutch News Service

New findings suggest that the gut microbiome’s influence on the childhood immune system may be the reason a promising experimental HIV vaccine failed to protect people from infection with the virus in recent clinical trials.

View story >

Thai HIV vaccine trial follow-up studies offer possible explanation for HIV prevention success

Peter Gilbert and SCHARP researchers, HVTN Laboratory Program, part of worldwide effort to understand trial outcome, influence future HIV vaccine studies

April 9, 2012

Fred Hutchinson Cancer Research Center researchers played a key role in the discovery of important immune responses that may have protected some volunteers from HIV in the RV144 Thai trial, the first HIV vaccine trial to show modest effectiveness in preventing HIV infection. Results from extensive RV144 laboratory studies were published April 5 in the New England Journal of Medicine.

View story >

Edlefsen joins growing Population Sciences program

Harvard-trained researcher to conduct genomic analyses of cancers, HIV

Aug. 2, 2010 | By Colleen Steelquist

Dr. Paul Edlefsen, a biostatistics and bioinformatics researcher, recently joined the Fred Hutchinson Cancer Research Center's Public Health Sciences and Vaccine and Infectious Disease divisions.

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.